These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9137700)

  • 1. [Appearance of antiphospholipid antibodies in patients with hepatitis C treated with interferon-alpha].
    Doutre MS; Baquey A; Bernard P; Couzigou P; Bernard N; Lacoste D; Morlat P
    Ann Med Interne (Paris); 1997; 148(1):99-100. PubMed ID: 9137700
    [No Abstract]   [Full Text] [Related]  

  • 2. [How should hepatitis C be monitored? Monitoring of treated hepatitis C].
    Larrey D
    Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S99-110. PubMed ID: 9161521
    [No Abstract]   [Full Text] [Related]  

  • 3. [Eruptive mucocutaneous lichen planus during treatment of chronic hepatitis C with interferon alpha].
    Sassigneux P; Michel P; Joly P; Colin R
    Gastroenterol Clin Biol; 1993; 17(10):764. PubMed ID: 8288088
    [No Abstract]   [Full Text] [Related]  

  • 4. [Interferon-alpha in the treatment of chronic viral hepatitis].
    Melman ML
    Rev Gastroenterol Mex; 1994; 59(2 Suppl):46-8. PubMed ID: 8091094
    [No Abstract]   [Full Text] [Related]  

  • 5. Immune thrombocytopenia after alpha-interferon therapy in a patient with chronic hepatitis C.
    López Morante AJ; Sáez-Royuela F; Casanova Valero F; Yuguero del Moral L; Martín Lorente JL; Ojeda Giménez C
    Am J Gastroenterol; 1992 Jun; 87(6):809-10. PubMed ID: 1590332
    [No Abstract]   [Full Text] [Related]  

  • 6. Canities and vitiligo complicating interferon therapy for hepatitis C.
    Bernstein D; Reddy KR; Jeffers L; Schiff E
    Am J Gastroenterol; 1995 Jul; 90(7):1176-7. PubMed ID: 7611226
    [No Abstract]   [Full Text] [Related]  

  • 7. [Parkinsonism in a patient receiving interferon alpha therapy for chronic hepatitis C].
    Mizoi Y; Kaneko H; Oharazawa A; Kuroiwa H
    Rinsho Shinkeigaku; 1997 Jan; 37(1):54-6. PubMed ID: 9146076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axonal neuropathy in a patient receiving interferon-alpha therapy for chronic hepatitis C.
    Tambini R; Quattrini A; Fracassetti O; Nemni R
    J Rheumatol; 1997 Aug; 24(8):1656-7. PubMed ID: 9263170
    [No Abstract]   [Full Text] [Related]  

  • 9. [Should hepatitis C be treated? Which biological tests are useful before deciding or refuting a treatment with interferon-alpha in patients with chronic hepatitis C?].
    Pawlotsky JM
    Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S41-50. PubMed ID: 9161513
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of treatment with two different doses of leukocyte interferon alpha in patients with chronic hepatitis C.
    Laghi V; Toccaceli F; Rosati S; Monini A; Grimaldi M; Foglianti G; Canova N; Palazzini E
    Hepatogastroenterology; 1997; 44(16):1182-6. PubMed ID: 9261621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is interferon-alpha therapy safe and effective for patients with chronic hepatitis C and inflammatory bowel disease? A case-control study.
    Bargiggia S; Thorburn D; Anderloni A; Ardizzone S; Giorgi A; Bianchi Porro G; Parente F
    Aliment Pharmacol Ther; 2005 Aug; 22(3):209-15. PubMed ID: 16091058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic response to alpha-interferon in chronic alcoholics with viral hepatitis C].
    Nikitin IG; Kuznetsov SL; Liuliaeva OD; Storozhakov GI; Kisliakov VA; Uskov IuI
    Klin Med (Mosk); 1998; 76(8):33-5. PubMed ID: 9770965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Severe hypertriglyceridemia during the course of treatment with interferon-alpha in a patient with chronic hepatitis C].
    Bory E; García Rico A; Pedro-Botet J; Sola R
    Gastroenterol Hepatol; 1996 Dec; 19(10):542. PubMed ID: 9044758
    [No Abstract]   [Full Text] [Related]  

  • 14. [How should hepatitis C be treated? Treatment of hepatitis C with interferon].
    Marcellin P
    Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S81-8. PubMed ID: 9161518
    [No Abstract]   [Full Text] [Related]  

  • 15. [Monitoring of treated or non-treated chronic viral hepatitis C. 2: Criteria of efficacy and monitoring of treatment with interferon-alpha].
    Payen JL
    Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S175-89. PubMed ID: 9161529
    [No Abstract]   [Full Text] [Related]  

  • 16. Side effects of alpha interferon in chronic hepatitis C.
    Dusheiko G
    Hepatology; 1997 Sep; 26(3 Suppl 1):112S-121S. PubMed ID: 9305675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The treatment of chronic viral hepatitis B/D and acute and chronic viral hepatitis C. The consensus of the German Society for Digestive and Metabolic Diseases].
    Hopf U; Niederau C; Kleber G; Fleig WE
    Z Gastroenterol; 1997 Nov; 35(11):971-86. PubMed ID: 9490556
    [No Abstract]   [Full Text] [Related]  

  • 18. Interferon-alpha neutralizing antibodies in HIV and chronic HCV patients treated with natural-source human leukocyte-derived interferon-alpha n3.
    Zhao XX; Hua J; Smith T; Ferencz-Biro K; Liao MJ; Rashidbaigi A
    Hum Antibodies; 1997; 8(3):129-36. PubMed ID: 9322083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy of hepatitis C: re-treatment with alpha interferon.
    Alberti A; Chemello L; Noventa F; Cavalletto L; De Salvo G
    Hepatology; 1997 Sep; 26(3 Suppl 1):137S-142S. PubMed ID: 9305679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Should hepatitis C be treated? What are indications of treatment in chronic hepatitis C?].
    Pascal JP
    Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S70-9. PubMed ID: 9161517
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.